Grufity logoGrufity logo
Stocks
Funds
Screener
Sectors
Watchlists
IQV

IQV - IQVIA Holdings Inc Stock Price, Fair Value and News

$164.71+1.78 (+1.09%)
Delayed

50/100

IQV

STOCK SCORE

High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 10 years

50/100

IQV

STOCK SCORE

High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 10 years

Price Targets

Target 1Y

Login to View

Target 6M

Login to View

IQV Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

IQV Price Action

Last 7 days

-5.6%

Last 30 days

-7.0%

Last 90 days

-25.9%

Trailing 12 Months

-9.2%

IQV RSI Chart

IQV Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

IQV Valuation

Market Cap

28.0B

Price/Earnings (Trailing)

20.55

Price/Sales (Trailing)

1.71

EV/EBITDA

7.5

Price/Free Cashflow

10.53

IQV Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

Price Targets

Target 1Y

Login to View

Target 6M

Login to View

IQV Fundamentals

IQV Revenue

Revenue (TTM)

16.3B

Rev. Growth (Yr)

10.26%

Rev. Growth (Qtr)

6.44%

IQV Earnings

Earnings (TTM)

1.4B

Earnings Growth (Yr)

17.62%

Earnings Growth (Qtr)

55.29%

IQV Profitability

EBT Margin

9.75%

Return on Equity

20.91%

Return on Assets

4.54%

Free Cashflow Yield

9.5%

IQV Investor Care

Buy Backs (1Y)

3.63%

Diluted EPS (TTM)

7.85

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
202515.5B15.7B15.9B16.3B
202415.1B15.2B15.3B15.4B
202314.5B14.7B14.9B15.0B
202214.0B14.1B14.3B14.4B
202112.0B12.9B13.5B13.9B
202011.2B10.9B11.0B11.4B
201910.5B10.7B10.9B11.1B
20189.9B10.1B10.2B10.4B
20177.7B8.5B9.5B9.7B
20165.9B6.0B6.1B6.8B
20155.5B5.6B5.6B5.7B
20145.2B5.2B5.4B5.5B
20134.9B5.0B5.0B5.1B
20124.5B4.6B4.7B4.9B
20110004.3B
Get all data in R, Python etc through our Historical Stock Data APIs

About IQVIA Holdings Inc

IQV
IQVIA Holdings Inc. engages in the provision of advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment offers a range of cloud-based applications and related implementation services; real world solutions that enable life sciences and provider customers to generate and disseminate evidence, which informs health care decision making and improves patients' outcomes; and strategic and implementation consulting services, such as advanced analytics and commercial processes outsourcing services. This segment also provides country level performance metrics related to sales of pharmaceutical products, prescribing trends, medical treatment, and promotional activity across various channels, including retail, hospital, and mail order; and measurement of sales or prescribing activity at the regional, zip code, and individual prescriber level. The Research & Development Solutions segment offers project management and clinical monitoring; clinical trial support; strategic planning and design services; and decentralized clinical trials, as well as central laboratory, genomic, bioanalytical, ADME, discovery, and vaccine and biomarker laboratory services. The Contract Sales & Medical Solutions segment provides health care provider and patient engagement services, and scientific strategy and medical affairs services. It serves pharmaceutical, biotechnology, device and diagnostic, and consumer health companies. The company was formerly known as Quintiles IMS Holdings, Inc. and changed its name to IQVIA Holdings Inc. in November 2017. IQVIA Holdings Inc. was incorporated in 2016 and is headquartered in Durham, North Carolina.
 CEO
 WEBSITEiqvia.com
 SECTORHealthcare
 INDUSTRYDiagnostics & Research
 EMPLOYEES65535

IQVIA Holdings Inc Frequently Asked Questions

IQV is the stock ticker symbol of IQVIA Holdings Inc. Every public company that trades on a stock exchange gets a ticker symbol.

As of Fri Mar 13 2026, market cap of IQVIA Holdings Inc is 27.95 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

As of Fri Mar 13 2026, IQV's PE ratio (Price to Earnings) is 20.55 and Price to Sales (PS) ratio is 1.71. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. IQV PE ratio will change depending on the future growth rate expectations of investors.

In the past 10 years, IQVIA Holdings Inc has provided 0.097 (multiply by 100 for percentage) rate of return.